SHANGHAI, Sept 23 (Reuters) - Innovent Biologics' (1801.HK), opens new tab newly launched weight-loss drug is making inroads in its home market of China, ramping up competition with its Western rivals ...
Berberine is an alkaloid compound found in plants with over 400-500 species. It has recently become popular as a potential ...
NEW YORK (Reuters) -Some Chinese companies now racing to make generic versions of Novo Nordisk's Wegovy also supplied ingredients for more than a billion makeshift doses of weight-loss drugs sold ...
Yang, 23, quit her teaching job earlier this year and signed up for a weight-loss camp on the outskirts of southwestern megacity Chengdu, and since then has followed a rigorous regime of diet and ...
Merck on Wednesday said it has snagged the rights to an experimental weight loss pill from Chinese drugmaker Hansoh Pharma, in a deal worth up to $2 billion. Merck will pay Hansoh $112 million upfront ...
Dual glucagon (GCG) and GLP-1 agonist mazdutide is already approved for both type 2 diabetes and obesity in China at doses ...
SHANGHAI, Oct 27 (Reuters) - China's Innovent Biologics (1801.HK), opens new tab said, opens new tabon Monday its GLP-1 injection led to more weight loss and better control of blood sugar in patients ...
China’s urban consumer boom has long been defined by indulgence. The rise of bubble-tea chains, hotpot restaurants and snack-delivery apps symbolized a growing middle class eager to spend money on ...
At the ObesityWeek 2024, AstraZeneca Plc (NASDAQ:AZN) shared data abstracts highlighting early data from AZD5004/ECC5004. In November 2023, AstraZeneca announced an exclusive license agreement with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results